1. Andersson J, Fehniger T, Björk L, Andersson U (1996) Intravenous immune glubulin has effects on superantigen-induced cytokine synthesis. Infusionsther Transfusionsmed 23 (Supp14): 7–14
2. Andersson JP, Andersson UG (1990) Human intravenous immunglobulin modulates monokine production in vitro. Immunology 71: 372–376
3. Andersson UG, Björk L, Skansén-Saphir U, Andersson JP (1993) Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79: 211–216
4. Baumgartner JD (1990) Arguments for the administration of immunglobulins in critically-ill patients. In: Peter K, Lawin P. Bein T, Briegel J (Hrsg) Intensivmedizin 1990. Thieme, Stuttgart New York (Intensivmedizin Notfallmedizin Anästhesie, Bd 81 ), S 152–157
5. Behre G, Ostermann H, Schedel I et al. (1995) Endotoxin concentrations and therapy with polyclonal IgM-enriched immunoglobulins in neutropenic cancer patients with sepsis syndrome: Pilot study and interim analysis of a randomized trial. Antiinfect DrugsChemothe 13: 129–134